Published in Circulation on October 27, 2008
MSCs for Prevention of MI-induced HF (PREVENT-TAHA) | NCT05043610
Epidemiology and risk profile of heart failure. Nat Rev Cardiol (2010) 4.88
Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation (2009) 3.45
Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell (2012) 3.33
National trends in rates of death and hospital admissions related to acute myocardial infarction, heart failure and stroke, 1994-2004. CMAJ (2009) 2.89
Epidemiology of heart failure. Circ Res (2013) 2.84
Targeting interleukin-1 in heart disease. Circulation (2013) 2.52
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A (2011) 1.81
National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010. Circulation (2013) 1.70
Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol (2010) 1.69
Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model. Obes Surg (2015) 1.60
Rheb is a critical regulator of autophagy during myocardial ischemia: pathophysiological implications in obesity and metabolic syndrome. Circulation (2012) 1.56
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial. Circ Res (2014) 1.55
Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure. J Am Coll Cardiol (2014) 1.54
Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome. Circ Cardiovasc Imaging (2016) 1.44
The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol (2011) 1.39
Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J Biol Chem (2012) 1.18
CaMKII and a failing strategy for growth in heart. J Clin Invest (2009) 1.13
Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction. Basic Res Cardiol (2011) 1.12
Targeting inflammatory pathways in myocardial infarction. Eur J Clin Invest (2013) 1.10
Heart failure after acute myocardial infarction: a lost battle in the war on heart failure? Circulation (2008) 1.10
The evolving epidemiology of acute coronary syndromes. Nat Rev Cardiol (2010) 1.09
Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death. Circulation (2011) 1.09
Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PLoS One (2012) 1.05
Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia. J Am Heart Assoc (2013) 1.02
Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study. Am J Epidemiol (2013) 1.01
Cardiogenesis from human embryonic stem cells. Circ J (2010) 1.00
Aging of the United States population: impact on heart failure. Curr Heart Fail Rep (2012) 1.00
Cell-based therapy for heart disease: a clinically oriented perspective. Mol Ther (2009) 1.00
Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study. Basic Res Cardiol (2011) 0.99
Development of a closed chest model of chronic myocardial infarction in Swine: magnetic resonance imaging and pathological evaluation. ISRN Cardiol (2013) 0.97
Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc (2012) 0.92
Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol (2012) 0.89
Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction. Circulation (2015) 0.89
Heart failure in North America. Curr Cardiol Rev (2013) 0.87
Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach. Basic Res Cardiol (2011) 0.87
Clinical effects of Xinmailong therapy in patients with chronic heart failure. Int J Med Sci (2013) 0.87
Intracoronary infusion of mononuclear cells after PCI-treated myocardial infarction and arrhythmogenesis: is it safe? Neth Heart J (2012) 0.86
Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation. Basic Res Cardiol (2012) 0.85
Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. Am Heart J (2014) 0.84
A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI). BMJ Open (2014) 0.84
Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective. Circ Heart Fail (2015) 0.83
Infarct healing is a dynamic process following acute myocardial infarction. J Cardiovasc Magn Reson (2012) 0.83
Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition. J Cell Mol Med (2015) 0.82
Blood aldosterone-to-renin ratio, ambulatory blood pressure, and left ventricular mass in children. J Pediatr (2009) 0.82
Trends in hospitalized acute myocardial infarction patients with heart failure in Korea at 1998 and 2008. J Korean Med Sci (2014) 0.81
Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism. Sci Rep (2016) 0.80
Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients. Cardiovasc Diabetol (2013) 0.79
Blood vessel repair and regeneration in the ischaemic heart. Open Heart (2014) 0.79
Directed epicardial assistance in ischemic cardiomyopathy: flow and function using cardiac magnetic resonance imaging. Ann Thorac Surg (2013) 0.79
Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium. J Mol Endocrinol (2016) 0.78
Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction. PLoS One (2012) 0.78
National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010. J Am Heart Assoc (2014) 0.78
Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. Heart Fail Rev (2015) 0.78
Predictive value of the fragmented QRS complex in 6-month mortality and morbidity following acute coronary syndrome. Int J Gen Med (2013) 0.77
Bayesian analysis of multi-type recurrent events and dependent termination with nonparametric covariate functions. Stat Methods Med Res (2015) 0.77
Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion. Immun Inflamm Dis (2015) 0.77
Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy. Int J Mol Med (2014) 0.77
Simulation model for cost estimation of integrated care concepts of heart failure patients. Health Econ Rev (2013) 0.77
Intracoronary Transplantation of Mesenchymal Stem Cells with Overexpressed Integrin-Linked Kinase Improves Cardiac Function in Porcine Myocardial Infarction. Sci Rep (2016) 0.77
Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy? Clin Res Cardiol (2011) 0.77
Association Between HIV Infection and the Risk of Heart Failure With Reduced Ejection Fraction and Preserved Ejection Fraction in the Antiretroviral Therapy Era: Results From the Veterans Aging Cohort Study. JAMA Cardiol (2017) 0.77
Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology. Br J Pharmacol (2013) 0.76
Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model. Circ Cardiovasc Interv (2016) 0.75
The transcription factor GATA4 promotes myocardial regeneration in neonatal mice. EMBO Mol Med (2017) 0.75
Heart Failure in Women--Insights from the Framingham Heart Study. Cardiovasc Drugs Ther (2015) 0.75
Heart Failure Predictors in a Group of Patients with Myocardial Infarction. Open Access Maced J Med Sci (2016) 0.75
Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives. Heart Fail Rev (2016) 0.75
Influence on prognosis and prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome. Rev Bras Ter Intensiva (2012) 0.75
Total Mechanical Unloading Minimizes Metabolic Demand of Left Ventricle and Dramatically Reduces Infarct Size in Myocardial Infarction. PLoS One (2016) 0.75
Cardiac repair in a mouse model of acute myocardial infarction with trophoblast stem cells. Sci Rep (2017) 0.75
Roles of SIRT3 in heart failure: from bench to bedside. J Zhejiang Univ Sci B (2016) 0.75
Chitosan hydrogel improves mesenchymal stem cell transplant survival and cardiac function following myocardial infarction in rats. Exp Ther Med (2017) 0.75
Positive feedback in cardioprotection: can more mechanism lead to translation? Circ Res (2014) 0.75
Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT). J Card Fail (2012) 0.75
Direct intracardiac injection of umbilical cord-derived stromal cells and umbilical cord blood-derived endothelial cells for the treatment of ischemic cardiomyopathy. Exp Biol Med (Maywood) (2015) 0.75
Impact of neonatal sertraline exposure on the post-myocardial infarction outcomes of adult male mice. J Cardiovasc Pharmacol (2013) 0.75
Prognostic Value of Soluble ST2 after Myocardial Infarction: A Community Perspective. Am J Med (2017) 0.75
Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. World J Cardiol (2017) 0.75
Changes and classification in myocardial contractile function in the left ventricle following acute myocardial infarction. J R Soc Interface (2017) 0.75
Myoblast transplantation improves cardiac function after myocardial infarction through attenuating inflammatory responses. Oncotarget (2017) 0.75
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow Function. Circ Res (2017) 0.75
Native T1 value in the remote myocardium is independently associated with left ventricular dysfunction in patients with prior myocardial infarction. J Magn Reson Imaging (2017) 0.75
Extra-cellular expansion in the normal, non-infarcted myocardium is associated with worsening of regional myocardial function after acute myocardial infarction. J Cardiovasc Magn Reson (2017) 0.75
Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases. Heart Fail Rev (2017) 0.75
Acute CD47 Blockade During Ischemic Myocardial Reperfusion Enhances Phagocytosis-Associated Cardiac Repair. JACC Basic Transl Sci (2017) 0.75
Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health (1951) 20.27
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2006) 19.43
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation (2000) 7.12
Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med (1998) 7.12
A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med (1995) 5.22
Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation (1998) 3.68
Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol (2000) 3.67
Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation (2004) 3.12
A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol (2004) 2.10
Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol (2003) 2.03
Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol (1999) 1.87
Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance. Am J Cardiol (2006) 1.48
Temporal trends in event rates after Q-wave myocardial infarction: the Framingham Heart Study. Circulation (1999) 1.41
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol (2003) 1.32
Heart failure after myocardial infarction: clinical presentation and survival. Eur J Heart Fail (2005) 1.26
Epidemiology of myocardial infarction. Med Clin North Am (2007) 1.18
Measurement of ejection fraction after myocardial infarction in the population. Chest (2004) 1.13
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med (2010) 14.49
Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (2010) 14.07
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med (2004) 11.46
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Incidence of diabetes in youth in the United States. JAMA (2007) 8.70
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation (2005) 8.54
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Predictors of new-onset kidney disease in a community-based population. JAMA (2004) 7.45
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation (2003) 7.40
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics (2006) 7.19
Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med (2004) 7.12
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95
Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med (2002) 6.92
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA (2002) 6.84
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med (2004) 6.42
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29